Review: taking Victoza and Humalog together


Summary

Drug interactions are reported among people who take Victoza and Humalog together. This review analyzes the effectiveness and drug interactions between Victoza and Humalog. It is created by eHealthMe based on reports of 500 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Victoza

Victoza has active ingredients of liraglutide. It is often used in type 2 diabetes. (latest outcomes from Victoza 22,251 users)

Humalog

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. (latest outcomes from Humalog 66,298 users)

On Sep, 17, 2016

500 people who take Victoza, Humalog are studied.


Number of reports submitted per year:

Victoza and Humalog drug interactions.

Drug effectiveness over time:

Victoza:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Humalog:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Victoza:
  • female: 50.0% - (1 of 2 people)
  • male: 75.0% - (3 of 4 people)
Humalog:
  • female: 0.0% - (0 of 2 people)
  • male: 75.0% - (3 of 4 people)

Drug effectiveness by age:

Victoza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 75.0% - (3 of 4 people)
  • 60+: 0.0% - (0 of 0 people)
Humalog:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 75.0% - (3 of 4 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • dehydration
  • diabetic ketoacidosis
  • vomiting
  • renal failure
  • depressed level of consciousness
  • liver disorder
  • pancreatitis
  • pancreatitis acute
  • diarrhoea
  • blood glucose increased
1 - 6 months:
  • pancreatic carcinoma
  • dehydration
  • nausea
  • vomiting
  • abdominal pain upper
  • adenocarcinoma pancreas
  • anaemia
  • atrial fibrillation
  • blood disorder
  • blood glucose increased
6 - 12 months:
  • pancreatic carcinoma
  • adenocarcinoma pancreas
  • dehydration
  • pancreatitis
  • chest pain
  • dysarthria
  • glycosylated haemoglobin increased
  • hyperglycaemia
  • hypoglycaemia
  • pancreatitis acute
1 - 2 years:
  • adenocarcinoma pancreas
  • pancreatic carcinoma
  • pancreatic carcinoma metastatic
  • pancreatitis
  • colitis
  • dehydration
  • dermatitis infected
  • diarrhoea
  • dizziness
  • dysphagia
2 - 5 years:
  • weight decreased
  • abdominal discomfort
  • blood glucose abnormal
  • blood glucose decreased
  • blood glucose increased
  • nausea
  • adenocarcinoma pancreas
  • decreased appetite
  • vomiting
  • headache
5 - 10 years:
  • erectile dysfunction
  • pancreatic carcinoma
10+ years:
  • bladder cancer
  • blood urine
  • night sweats
not specified:
  • blood glucose increased
  • nausea
  • blood glucose decreased
  • weight decreased
  • vomiting
  • glycosylated haemoglobin increased
  • headache
  • decreased appetite
  • diarrhoea
  • drug ineffective

Most common drug interactions by gender *:

female:
  • blood glucose increased
  • nausea
  • blood glucose decreased
  • weight decreased
  • glycosylated haemoglobin increased
  • decreased appetite
  • dehydration
  • vomiting
  • headache
  • pancreatic carcinoma
male:
  • blood glucose increased
  • nausea
  • vomiting
  • blood glucose decreased
  • malaise
  • weight decreased
  • depressed level of consciousness
  • headache
  • diarrhoea
  • drug ineffective

Most common drug interactions by age *:

10-19:
  • fluid retention
  • pancytopenia
  • staphylococcal sepsis
  • anaphylactic reaction
  • diarrhoea
20-29:
  • maternal exposure during pregnancy
  • abortion induced
  • pregnancy
30-39:
  • blood glucose decreased
  • blood glucose increased
  • diabetic ketoacidotic hyperglycaemic coma
  • vomiting
  • autoimmune hepatitis
  • cardiac failure
  • cardiomyopathy
  • cataplexy
  • chest pain
  • cholangiocarcinoma
40-49:
  • diabetic ketoacidosis
  • malaise
  • nausea
  • blood glucose increased
  • diarrhoea
  • frequent bowel movements
  • headache
  • hepatic steatosis
  • neck mass
  • pain
50-59:
  • blood glucose increased
  • adenocarcinoma pancreas
  • nausea
  • blood glucose decreased
  • injection site pain
  • pancreatic carcinoma
  • pancreatic carcinoma stage iv
  • pancreatitis
  • glycosylated haemoglobin increased
  • headache
60+:
  • blood glucose increased
  • nausea
  • blood glucose decreased
  • weight decreased
  • dehydration
  • vomiting
  • decreased appetite
  • diarrhoea
  • renal failure
  • pancreatic carcinoma

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Victoza and Humalog?

Can you answer these questions?

More questions for: Victoza, Humalog

You may be interested in these reviews

More reviews for: Victoza, Humalog

On eHealthMe, Victoza (liraglutide) is often used to treat type 2 diabetes. Humalog (insulin lispro recombinant) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.